InvestorsObserver
×
News Home

Should You Sell Jasper Therapeutics Inc (JSPR) Stock Friday Morning?

Friday, October 22, 2021 08:28 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Jasper Therapeutics Inc (JSPR) Stock Friday Morning?

Jasper Therapeutics Inc (JSPR) is lower by Friday morning, with the stock falling -1.89% in pre-market trading to 13. JSPR's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, JSPR ranks higher than 86% of stocks. Jasper Therapeutics Inc has risen 24.41% over the past month, closing at $15.12 on September 24. During this period of time, the stock fell as low as $7.21 and as high as $18.88. JSPR has an average analyst recommendation of Strong Buy. The company has an average price target of $21.00.

Overall Score - 72
JSPR has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on JSPR!
Jasper Therapeutics Inc has a Long-Term Technical rank of 94. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 6% of the market scoring higher. In the Biotechnology industry which is number 136 by this metric, JSPR ranks better than 97% of stocks.

Important Dates for Investors in JSPR:

-We do not have a set earnings date for Jasper Therapeutics Inc at this time. -We do not have a set dividend date for Jasper Therapeutics Inc at this time. Click Here To Get The Full Report on Jasper Therapeutics Inc (JSPR)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App